明德生物拟参与投资泽森聚芯贰号

Core Viewpoint - Mingde Bio (002932) has announced its participation in the Wuhan Zesen Juxin No. 2 Venture Capital Partnership, contributing 30 million yuan and holding a 31.5789% stake in the fund, which has a total size of 95 million yuan [1]. Group 1 - The fund, Wuhan Zesen Juxin No. 2, focuses on investment areas such as optoelectronics, semiconductors, artificial intelligence, and high-end manufacturing [1]. - The investment stages covered by the fund include early-stage, growth-stage, and mature-stage investments [1].